Harry Glorikian introduces AIDET, a framework for understanding how AI is transforming entire business ecosystems, not just single tasks.
Inspired by Ethan Mollick’s essay, Harry Glorikian explains why steady, incremental AI progress may be more transformative than any single breakthrough.
Harry Glorikian outlines the three phases companies move through as they adopt AI, from efficiency gains to true innovation.
Harry Glorikian shares a personal reflection on failure, risk-taking, and what real growth requires.
Harry Glorikian discusses how to adapt personally and professionally as the pace of AI innovation accelerates.
Harry Glorikian shares takeaways from the GBS Dubai Summit, where 1,300 global CEOs discussed navigating the AI revolution.
Harry Glorikian explains how AI has moved from a niche experiment to a necessity reshaping business leadership and strategy.
AI in drug discovery is headline news, but the deeper shift is in pharma’s architecture, business models and talent requirements. Here is what is changing.